Toward equitable transplant protocols: Thymoglobulin vs. Basiliximab in African-American kidney transplantation shows higher infection risk without survival benefit
{{output}}
In kidney transplantation, induction therapy is often selected based on perceived immunologic risk for acute rejection, commonly considering African American (AA) ethnicity, panel reactive antibody (PRA) levels > 20%, and retransplantation. ... ...
